Unicycive Therapeutics, Inc., (UNCY): Price and Financial Metrics

Unicycive Therapeutics, Inc., (UNCY): $0.54

0.02 (-3.74%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add UNCY to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#111 of 326

in industry

UNCY Price/Volume Stats

Current price $0.54 52-week high $1.73
Prev. close $0.56 52-week low $0.20
Day low $0.53 Volume 627,000
Day high $0.58 Avg. volume 1,024,433
50-day MA $0.62 Dividend yield N/A
200-day MA $0.54 Market Cap 56.36M

UNCY Stock Price Chart Interactive Chart >


Unicycive Therapeutics, Inc., (UNCY) Company Bio


Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.


UNCY Latest News Stream


Event/Time News Detail
Loading, please wait...

UNCY Latest Social Stream


Loading social stream, please wait...

View Full UNCY Social Stream

UNCY Price Returns

1-mo -4.53%
3-mo -32.46%
6-mo 42.11%
1-year -63.76%
3-year -58.78%
5-year N/A
YTD -32.01%
2024 -8.47%
2023 60.69%
2022 -73.79%
2021 N/A
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!